VKTX vs. IVV
Compare and contrast key facts about Viking Therapeutics, Inc. (VKTX) and iShares Core S&P 500 ETF (IVV).
IVV is a passively managed fund by iShares that tracks the performance of the S&P 500 Index. It was launched on May 15, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VKTX or IVV.
Correlation
The correlation between VKTX and IVV is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VKTX vs. IVV - Performance Comparison
Key characteristics
VKTX:
0.86
IVV:
2.18
VKTX:
2.83
IVV:
2.90
VKTX:
1.36
IVV:
1.40
VKTX:
2.17
IVV:
3.28
VKTX:
3.79
IVV:
14.15
VKTX:
34.05%
IVV:
1.95%
VKTX:
149.93%
IVV:
12.64%
VKTX:
-90.41%
IVV:
-55.25%
VKTX:
-55.92%
IVV:
-2.81%
Returns By Period
In the year-to-date period, VKTX achieves a 3.53% return, which is significantly higher than IVV's 0.49% return.
VKTX
3.53%
-17.99%
-23.07%
113.86%
40.24%
N/A
IVV
0.49%
-2.81%
6.62%
25.82%
14.33%
13.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VKTX vs. IVV — Risk-Adjusted Performance Rank
VKTX
IVV
VKTX vs. IVV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VKTX vs. IVV - Dividend Comparison
VKTX has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.29%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
iShares Core S&P 500 ETF | 1.29% | 1.30% | 1.44% | 1.66% | 1.20% | 1.57% | 1.99% | 2.21% | 1.75% | 2.01% | 2.27% | 1.83% |
Drawdowns
VKTX vs. IVV - Drawdown Comparison
The maximum VKTX drawdown since its inception was -90.41%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for VKTX and IVV. For additional features, visit the drawdowns tool.
Volatility
VKTX vs. IVV - Volatility Comparison
Viking Therapeutics, Inc. (VKTX) has a higher volatility of 24.09% compared to iShares Core S&P 500 ETF (IVV) at 4.46%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.